Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
277 results found
2023 ∙ Conseil Supérieur de la Santé (CSS)
Pneumococcal vaccination in children and adolescents in Belgium
Recommendation Europe Belgium Children Adolescents Pneumococcal disease
Download:
2022 ∙ Nor, S. F. S. Aminuddin, N. A. Ahmad, N. Hassan, M. R. Nawi, A. M. Ahmad, N. Pang, N. T. P. Omar, A. Madrim, M. F. Mokti, K. Ramdzan, A. R. Rahim, S. S. S. A. Jeffree, M. S.
A Systematic Review and Meta-Analysis of Mobile Phone Messaging Intervention on Vaccine Preventable Diseases
Adults Parents/caregivers Pregnant women Influenza Pneumococcal disease Mumps Measles Rubella Coverage
Rating:
Not applicable
2022 ∙ Mungall, B. A. Hoet, B. Nieto Guevara, J. Soumahoro, L.
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children
Newborn Children Adolescents Pneumococcal disease Administration Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Parmar, K. Subramanyam, S. Del Rio-Pertuz, G. Sethi, P. Argueta-Sosa, E.
Cardiac Adverse Events after Vaccination—A Systematic Review
Adults COVID-19 Smallpox Influenza Pneumococcal disease Tetanus Cholera Safety
Rating:
Critically low
2022 ∙ Cardoso Pinto, A. M. Ranasinghe, L. Dodd, P. J. Budhathoki, S. S. Seddon, J. A. Whittaker, E.
Disruptions to routine childhood vaccinations in low- and middle-income countries during the COVID-19 pandemic: A systematic review
Newborn Children Low and Middle Income Countries Hepatitis B Poliomyelitis Diphtheria Pertussis Tetanus Haemophilus influenzae type B Pneumococcal disease Rotavirus Measles Human papillomavirus (HPV) Rubella Coverage
Rating:
Not applicable
2022 ∙ Jaiswal, V. Ang, S. P. Lnu, K. Ishak, A. Pokhrel, N. B. Chia, J. E. Hajra, A. Biswas, M. Matetic, A. Dhatt, R. Mamas, M. A.
Effect of Pneumococcal Vaccine on Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
Adolescents Adults Older adults Pneumococcal disease Safety
Rating:
Critically low
2022 ∙ Lenzing, E. Rezahosseini, O. Burgdorf, S. K. Nielsen, S. D. Harboe, Z. B.
Efficacy, immunogenicity, and evidence for best-timing of pneumococcal vaccination in splenectomized adults: a systematic review
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Müller, K. E. Dohos, D. Sipos, Z. Kiss, S. Dembrovszky, F. Kovács, N. Solymár, M. Erőss, B. Hegyi, P. Sarlós, P.
Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: A systematic review and meta-analysis of 1429 patients
Adults Older adults Pneumococcal disease Influenza Efficacy/effectiveness Safety
Rating:
Critically low
2022 ∙ Guzman-Holst, A. de Barros, E. Rubio, P. DeAntonio, R. Cintra, O. Abreu, A.
Impact after 10-year use of pneumococcal conjugate vaccine in the Brazilian national immunization program: an updated systematic literature review from 2015 to 2020
Americas Brazil All age groups Pneumococcal disease Efficacy/effectiveness Coverage
Rating:
Critically low
2022 ∙ Britt, A. F. Poupore, N. S. Nguyen, S. A. White, D. R.
Improving Pneumococcal Vaccination Rates in Cochlear Implant Programs: A Systematic Review and Meta-analysis
All age groups Pneumococcal disease Coverage
Rating:
Not applicable
Loading...